Back
Day Range
$29.49
$29.50
52-Week Range
$19.44
$42.81
Volume
1,129
50D / 200D Avg
$33.36
/
$35.01
Prev Close
$29.49
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 545.1 | 0.4 |
| P/B | 17.3 | 2.9 |
| ROE % | 3.4 | 3.8 |
| Net Margin % | 1.8 | 3.9 |
| Rev Growth 5Y % | 72.2 | 10.0 |
| D/E | 0.1 | 0.2 |
Key Takeaways
Revenue grew 72.16% annually over 5 years — strong growth
ROE of 3.37% is below average
Debt/Equity of 0.06 — conservative balance sheet
Negative free cash flow of -2.40M
P/E of 545.11 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 11.54%
Growth
Revenue Growth (5Y)
72.16%
Revenue (1Y)60.62%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
3.37%
ROIC7.75%
Net Margin1.75%
Op. Margin6.04%
Safety
Debt / Equity
0.06
Current Ratio1.96
Interest Coverage24.04
Valuation
P/E Ratio
545.11
P/B Ratio17.25
EV/EBITDA156.01
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 60.62% | Revenue Growth (3Y) | 90.15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 72.16% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 121.36M | Net Income (TTM) | 2.12M |
| ROE | 3.37% | ROA | 1.98% |
| Gross Margin | 86.39% | Operating Margin | 6.04% |
| Net Margin | 1.75% | Free Cash Flow (TTM) | -2.40M |
| ROIC | 7.75% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.06 | Current Ratio | 1.96 |
| Interest Coverage | 24.04 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 545.11 | P/B Ratio | 17.25 |
| P/S Ratio | 9.52 | PEG Ratio | -3.55 |
| EV/EBITDA | 156.01 | Dividend Yield | 0.00% |
| Market Cap | 1.16B | Enterprise Value | 1.14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 121.36M | 75.56M | 33.56M | 17.99M | 13.82M |
| Net Income | 2.12M | -3.72M | -13.73M | -14.60M | -7.54M |
| EPS (Diluted) | 0.05 | -0.10 | -0.38 | -0.43 | -0.23 |
| Gross Profit | 104.84M | 62.03M | 28.47M | 10.77M | 10.07M |
| Operating Income | 7.33M | -5.00M | -13.19M | -13.45M | -8.77M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 107.26M | 84.54M | 71.46M | 82.95M | 91.34M |
| Total Liabilities | 40.30M | 25.79M | 14.75M | 14.09M | 14.36M |
| Shareholders' Equity | 66.96M | 58.75M | 56.71M | 68.86M | 76.98M |
| Total Debt | 3.94M | 1.79M | 2.14M | 1.91M | 2.15M |
| Cash & Equivalents | 15.67M | 17.46M | 14.21M | 24.07M | 28.62M |
| Current Assets | 65.52M | 44.75M | 27.19M | 31.39M | 32.89M |
| Current Liabilities | 33.40M | 20.90M | 13.19M | 12.59M | 11.29M |